Business Description
Easton Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US2777741057
Compare
Compare
Traded in other countries / regions
EAPH.USA Description
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
3-1 Month Momentum % | 100 | |||||
6-1 Month Momentum % | 100 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
FCF Yield % | -2709100 |
GF Valueâ„¢
Easton Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Easton Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.000333:1 Stock Split | 2009-04-30 | 0.90 (-40.00%) |
Show
Entries
Guru Commentaries on OTCPK:EAPH
No articles.
Press Release
Articles on Easton Pharmaceuticals Inc
No articles.